Evidence map›Paper›PMID 39641118›Full record

ArticleEuropean urology open science2025

Assessing the Cause of Death for Men with Prostate Cancer Using Official Mortality Statistics or a Dedicated Cause of Death Committee: Results from 30-year ERSPC Rotterdam Data.

Sebastiaan Remmers, Ivo I de Vos, Frederique B Denijs, Renée C A Leenen, Tycho M T W Lock, Arjen Noordzij, Wim J Kirkels, Chris H Bangma, Monique J Roobol, ERSPC Rotterdam Study Group

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European urology open science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sebastiaan RemmersDepartment of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Ivo I de VosDepartment of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Frederique B DenijsDepartment of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Renée C A LeenenDepartment of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Tycho M T W LockDepartment of Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
Arjen NoordzijDepartment of Urology, Spaarne Gasthuis, Hoofddorp, The Netherlands.
Wim J KirkelsDepartment of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Chris H BangmaDepartment of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Monique J RoobolDepartment of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
ERSPC Rotterdam Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For men with prostate cancer (PCa) within the European Randomized Study of Screening for Prostate Cancer (ERSPC), the cause of death is determined by a Cause of Death Committee (CODC) that evaluates all medical records using a fixed algorithm. The aim of this study was to compare the classification of PCa-specific mortality (PCSM) between the CODC and Statistics Netherlands. We calculated the sensitivity (PCSM agreement divided by total PCSM deaths according to the CODC) and specificity (agreement for other-cause mortality [OCM] divided by total OCM deaths according to the CODC) using the last 21-yr follow-up data from ERSPC Rotterdam. For the core age group (age 55-69 yr at randomization; Patient summary: We compared the classification of prostate cancer death between a dedicated trial committee and official statistics in the Netherlands. We found that official statistics are an accurate representation in determining the cause of death.

Indexed as

Cause of deathComplicationsMortalityProstate cancerProstatic neoplasms

Identifiers

PMID39641118
PMCPMC11615526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.